163 related articles for article (PubMed ID: 29517678)
1. The clinical significance of COL5A2 in patients with bladder cancer: A retrospective analysis of bladder cancer gene expression data.
Zeng XT; Liu XP; Liu TZ; Wang XH
Medicine (Baltimore); 2018 Mar; 97(10):e0091. PubMed ID: 29517678
[TBL] [Abstract][Full Text] [Related]
2. DHCR24 predicts poor clinicopathological features of patients with bladder cancer: A STROBE-compliant study.
Liu XP; Yin XH; Meng XY; Yan XH; Cao Y; Zeng XT; Wang XH
Medicine (Baltimore); 2018 Sep; 97(39):e11830. PubMed ID: 30278482
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.
Lin YL; Wang YL; Ma JG; Li WP
J Exp Clin Cancer Res; 2014 Aug; 33(1):68. PubMed ID: 25927589
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Value of Cytokeratin and Extracellular Collagen Expression in Urinary Bladder Cancer.
Ingenwerth M; Nyirády P; Hadaschik B; Szarvas T; Reis H
Curr Mol Med; 2022; 22(10):941-949. PubMed ID: 33632097
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy.
Liu A; Xue Y; Liu F; Tan H; Xiong Q; Zeng S; Zhang Z; Gao X; Sun Y; Xu C
Cancer Biomark; 2019; 26(3):281-289. PubMed ID: 31594208
[TBL] [Abstract][Full Text] [Related]
6. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
Chen T; Xie W; Xie L; Sun Y; Zhang Y; Shen Z; Sha N; Xu H; Wu Z; Hu H; Wu C
Biochem Biophys Res Commun; 2015 Dec; 468(4):666-70. PubMed ID: 26551459
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival.
Xu Z; Yu YQ; Ge YZ; Zhu JG; Zhu M; Zhao YC; Xu LW; Yang XB; Geng LG; Dou QL; Jia RP
Tumour Biol; 2015 Sep; 36(10):8159-66. PubMed ID: 25990459
[TBL] [Abstract][Full Text] [Related]
8. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.
Tang K; Wang C; Chen Z; Xu H; Ye Z
Int J Clin Exp Pathol; 2015; 8(5):4999-5007. PubMed ID: 26191193
[TBL] [Abstract][Full Text] [Related]
10. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
Fang Z; Dai W; Wang X; Chen W; Shen C; Ye G; Li L
Tumour Biol; 2016 Jun; 37(6):8075-82. PubMed ID: 26715266
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
[TBL] [Abstract][Full Text] [Related]
12. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
13. COL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis.
Ding YL; Sun SF; Zhao GL
Medicine (Baltimore); 2021 Feb; 100(7):e24561. PubMed ID: 33607786
[TBL] [Abstract][Full Text] [Related]
14. Low-risk non-muscle-invasive bladder cancer: Further prognostic stratification into the "very-low-risk" group based on tumor size.
Lee A; Lee HJ; Huang HH; Ho H; Chen K
Int J Urol; 2019 Apr; 26(4):481-486. PubMed ID: 30834632
[TBL] [Abstract][Full Text] [Related]
15. Thyroid Receptor-Interacting Protein 13 is Correlated with Progression and Poor Prognosis in Bladder Cancer.
Niu L; Gao Z; Cui Y; Yang X; Li H
Med Sci Monit; 2019 Sep; 25():6660-6668. PubMed ID: 31486418
[TBL] [Abstract][Full Text] [Related]
16. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
[TBL] [Abstract][Full Text] [Related]
17. Loss of DUSP2 predicts a poor prognosis in patients with bladder cancer.
Yin H; He W; Li Y; Xu N; Zhu X; Lin Y; Gou X
Hum Pathol; 2019 Mar; 85():152-161. PubMed ID: 30458195
[TBL] [Abstract][Full Text] [Related]
18. Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer.
Blanca A; Sanchez-Gonzalez A; Requena MJ; Carrasco-Valiente J; Gomez-Gomez E; Cheng L; Cimadamore A; Montironi R; Lopez-Beltran A
APMIS; 2019 Aug; 127(8):545-553. PubMed ID: 31231851
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer.
Lai H; Cheng X; Liu Q; Luo W; Liu M; Zhang M; Miao J; Ji Z; Lin GN; Song W; Zhang L; Bo J; Yang G; Wang J; Gao WQ
Int J Cancer; 2021 Dec; 149(12):2099-2115. PubMed ID: 34480339
[TBL] [Abstract][Full Text] [Related]
20. Positive association of collagen type I with non-muscle invasive bladder cancer progression.
Brooks M; Mo Q; Krasnow R; Ho PL; Lee YC; Xiao J; Kurtova A; Lerner S; Godoy G; Jian W; Castro P; Chen F; Rowley D; Ittmann M; Chan KS
Oncotarget; 2016 Dec; 7(50):82609-82619. PubMed ID: 27655672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]